Suppr超能文献

blaTEM 进化中的适应性权衡。

Fitness trade-offs in blaTEM evolution.

作者信息

Mroczkowska Joanna E, Barlow Miriam

机构信息

University of California, Merced, Merced, California, USA.

出版信息

Antimicrob Agents Chemother. 2008 Jul;52(7):2340-5. doi: 10.1128/AAC.00018-08. Epub 2008 Apr 28.

Abstract

bla(TEM-1) expression results in penicillin resistance, whereas expression of many bla(TEM-1) descendants, called extended-spectrum beta-lactamases (ESBLs), results simultaneously in resistance to penicillins and extended-spectrum cephalosporins. Despite the expanded resistance phenotypes conferred by many ESBLs, bla(TEM-1) is still the most abundant bla(TEM) allele in many microbial populations. This study examines the fitness effects of the two amino acid substitutions, R164S and E240K, that have occurred repeatedly among ESBL bla(TEM-1) descendants. Using a single-nucleotide polymorphism-specific real-time quantitative PCR method, we analyzed the fitness of strains expressing bla(TEM-1), bla(TEM-10), and bla(TEM-12). Our results show that bacteria expressing the ancestral bla(TEM-1) allele have a fitness advantage over those expressing either bla(TEM-10) or bla(TEM-12) when exposed to ampicillin. This observation, combined with the fact that penicillins are the most prevalent antimicrobials prescribed worldwide, may explain why bla(TEM-1) has persisted as the most frequently encountered bla(TEM) allele in bacterial populations.

摘要

bla(TEM-1) 的表达会导致对青霉素产生耐药性,而许多 bla(TEM-1) 的衍生物(称为超广谱β-内酰胺酶,ESBLs)的表达则会同时导致对青霉素和超广谱头孢菌素产生耐药性。尽管许多ESBLs赋予了扩大的耐药表型,但 bla(TEM-1) 在许多微生物群体中仍然是最丰富的 bla(TEM) 等位基因。本研究考察了在ESBL bla(TEM-1) 衍生物中反复出现的两个氨基酸替换,即R164S和E240K,所产生的适应性影响。我们使用单核苷酸多态性特异性实时定量PCR方法,分析了表达 bla(TEM-1)、bla(TEM-10) 和 bla(TEM-12) 的菌株的适应性。我们的结果表明,当暴露于氨苄青霉素时,表达祖先 bla(TEM-1) 等位基因细菌比表达 bla(TEM-10) 或 bla(TEM-12) 的细菌具有适应性优势。这一观察结果,再结合青霉素是全球处方中最普遍使用的抗菌药物这一事实,或许可以解释为什么 bla(TEM-1) 一直是细菌群体中最常遇到的 bla(TEM) 等位基因。

相似文献

1
Fitness trade-offs in blaTEM evolution.
Antimicrob Agents Chemother. 2008 Jul;52(7):2340-5. doi: 10.1128/AAC.00018-08. Epub 2008 Apr 28.
5
Mechanisms of resistance to expanded-spectrum cephalosporins in Escherichia coli isolates recovered in a Spanish hospital.
J Antimicrob Chemother. 2005 Dec;56(6):1107-10. doi: 10.1093/jac/dki370. Epub 2005 Oct 20.
7
Evolution of TEM-type extended-spectrum beta-lactamases in clinical Enterobacteriaceae strains in Poland.
Antimicrob Agents Chemother. 2005 May;49(5):1872-80. doi: 10.1128/AAC.49.5.1872-1880.2005.
8
Extended-spectrum beta-lactamases in Ireland, including a novel enzyme, TEM-102.
Antimicrob Agents Chemother. 2003 Aug;47(8):2572-8. doi: 10.1128/AAC.47.8.2572-2578.2003.

引用本文的文献

5
Beyond horizontal gene transfer: the role of plasmids in bacterial evolution.
Nat Rev Microbiol. 2021 Jun;19(6):347-359. doi: 10.1038/s41579-020-00497-1. Epub 2021 Jan 19.
7
Abundances of Clinically Relevant Antibiotic Resistance Genes and Bacterial Community Diversity in the Weihe River, China.
Int J Environ Res Public Health. 2018 Apr 10;15(4):708. doi: 10.3390/ijerph15040708.
8
Multicopy plasmids allow bacteria to escape from fitness trade-offs during evolutionary innovation.
Nat Ecol Evol. 2018 May;2(5):873-881. doi: 10.1038/s41559-018-0529-z. Epub 2018 Apr 9.
9
Rational design of antibiotic treatment plans: a treatment strategy for managing evolution and reversing resistance.
PLoS One. 2015 May 6;10(5):e0122283. doi: 10.1371/journal.pone.0122283. eCollection 2015.
10
Klebsiella: a long way to go towards understanding this enigmatic jet-setter.
F1000Prime Rep. 2014 Aug 1;6:64. doi: 10.12703/P6-64. eCollection 2014.

本文引用的文献

1
European Surveillance of Antimicrobial Consumption (ESAC): outpatient cephalosporin use in Europe.
J Antimicrob Chemother. 2006 Aug;58(2):413-7. doi: 10.1093/jac/dkl185. Epub 2006 May 30.
2
European Surveillance of Antimicrobial Consumption (ESAC): outpatient penicillin use in Europe.
J Antimicrob Chemother. 2006 Aug;58(2):408-12. doi: 10.1093/jac/dkl186. Epub 2006 May 30.
3
European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe.
J Antimicrob Chemother. 2006 Aug;58(2):401-7. doi: 10.1093/jac/dkl188. Epub 2006 May 30.
4
Mechanisms of resistance to expanded-spectrum cephalosporins in Escherichia coli isolates recovered in a Spanish hospital.
J Antimicrob Chemother. 2005 Dec;56(6):1107-10. doi: 10.1093/jac/dki370. Epub 2005 Oct 20.
5
Extended-spectrum beta-lactamases: a clinical update.
Clin Microbiol Rev. 2005 Oct;18(4):657-86. doi: 10.1128/CMR.18.4.657-686.2005.
7
Occurrence and molecular analysis of extended-spectrum {beta}-lactamase-producing Proteus mirabilis in Hong Kong, 1999-2002.
J Antimicrob Chemother. 2005 Jun;55(6):840-5. doi: 10.1093/jac/dki135. Epub 2005 Apr 27.
8
Evolution of TEM-type extended-spectrum beta-lactamases in clinical Enterobacteriaceae strains in Poland.
Antimicrob Agents Chemother. 2005 May;49(5):1872-80. doi: 10.1128/AAC.49.5.1872-1880.2005.
9
Extended-spectrum beta-lactamases among Enterobacter isolates obtained in Tel Aviv, Israel.
Antimicrob Agents Chemother. 2005 Mar;49(3):1150-6. doi: 10.1128/AAC.49.3.1150-1156.2005.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验